Delivery Order SPE2DB22D9239-SPE2DB23FDL10
Award Date 7/20/23
Potential Completion Date 8/10/23
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $19,873 to DMS Pharmaceutical Group Inc. to supply the drug Soliris. The order is for 30 vials of the 300mg dosage to be delivered to a location in Park Ridge, Illinois, with performance required between late September and mid-October of 2023. No set aside designation or subcontractors were indicated. The DLA manages the Department of Defense's supplies including pharmaceuticals, so this order is...
- The Defense Logistics Agency Troop Support Medical awarded a $79,492 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4562162778 SOLIRIS 300 MG/30 ML VIAL 30ML. The place of performance is Park Ridge, Illinois and the period of performance is September 11, 2023 through October 2, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical...
- The Defense Logistics Agency (DOD) awarded a $173,888.75 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "SOLIRIS 300 MG/30 ML VIAL 30ML." The place of performance will be in Park Ridge, Illinois. The period of performance is from September 28, 2023 through October 20, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's armed forces by providing supplies in wartime and peacetime. This...
- The Defense Logistics Agency awarded a $59,619 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 30 vials of the drug Soliris (eculizumab) for intravenous administration. The place of performance is in Park Ridge, Illinois, with deliveries required between September 5-26, 2023. No subcontractors or set aside designations were identified. The DLA manages the Department of Defense's global supply chain and distribution network, procuring billions of dollars' worth of...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,029.16 contract, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division, is for the supply of Soliris 300 mg/30 ml vials to support the recurring medical needs of military health facilities. The delivery order, which has an ultimate completion date of June 6, 2024, is part of a larger...
- The Defense Logistics Agency awarded a $49,682.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for SOLIRIS 300 MG/30 ML VIAL 30ML under contract number 4562344612. The delivery order is for product delivery to a location in Park Ridge, Illinois, with performance period beginning September 25, 2023 through October 17, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed forces by providing supplies in...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $41,008.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Soliris 300 mg/30 mL vials. The delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $19,873 to DMS Pharmaceutical Group Inc. to supply SOLIRIS 300 MG/30 ML VIAL pharmaceutical products. Performance will take place in Park Ridge, Illinois over a three week period concluding in late August 2023. The award was issued utilizing an existing indefinite-delivery/indefinite-quantity contract vehicle but no set aside designation or subcontracting details were provided. The DLA supports...
- The Defense Logistics Agency awarded a $19,873 delivery order to DMS Pharmaceutical Group Inc. to supply 4561806823 SOLIRIS 300 MG/30 ML VIAL 30ML. The firm fixed price order is being funded by the Defense Logistics Agency and will be performed in Park Ridge, Illinois with work scheduled to be completed by August 29, 2023. SOLIRIS is a therapeutic medication used to treat certain rare diseases. This small order for SOLIRIS vials supports the Defense Logistics Agency's mission to provide...
- The U.S. Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $40,181.84 for Soliris 300 mg/30 mL vials. This award, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. The delivery order represents a single purchase transaction under DMS Pharmaceutical Group's larger Indefinite Delivery...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDL10Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $19,873 to DMS Pharmaceutical Group Inc. to supply the drug Soliris. The order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle and calls for DMS to deliver 30 vials of the 300mg formulation of Soliris. Performance will take place in Park Ridge, Illinois over a three week period concluding in mid-August. No set aside designation or subcontracting details were provided. The DLA manages the Department of Defense's supplies including pharmaceuticals, so this order is likely supporting medical treatment for military personnel, veterans, or other DOD beneficiaries.
Generated 12/22/23, 4:20 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.9k | 7/20/23 |